Uncontrolled hidradenitis suppurativa costs the health care system

WASHINGTON – One in four hidradenitis suppurativa patients saw their disease become more severe, requiring significantly more health care resources and driving up health care spending. Dr. Alexa Boer Kimball, professor of dermatology at Harvard Medical School, Boston, and her colleagues reviewed...
Source: Skin and Allergy News - Category: Dermatology Source Type: news